Remove Airlines Remove Artificial Intelligence Remove Fractional CTO
article thumbnail

Human vs. humane: How companies pursue AI for enhanced CX

CIO

Two thirds of the CX practitioners, service leaders, analysts, and consultants from around the world who took part in CX Network’s Global State of CX 2024 agreed or strongly agreed they’re increasingly concerned about the ethical use of AI and its future development.

Company 192
article thumbnail

Weighing the risks of moving too fast with gen AI

CIO

An airline chatbot gave a customer a discount it shouldn’t have, and a court held the company liable. Instead, they are focusing the technology on internal operations, where it can still make a meaningful difference without causing a huge PR disaster if something goes wrong. Instead, the nurses started quitting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Building a digital manufacturing foundation in the cloud

Capgemini

Less obvious is the role aerospace companies play as major parts suppliers to airlines around the world. Airlines cannot afford to have planes out of service, which means they cannot have parts out of stock. Director/Principal Consultant. Senior Manager/Managing Consultant. Consultant/Senior Consultant.

Cloud 52
article thumbnail

Why enterprise CIOs need to plan for Microsoft gen AI

CIO

Microsoft CTO Kevin Scott compared the company’s Copilot stack to the LAMP stack of Linux, Apache, MySQL and PHP, enabling organizations to build at scale on the internet, and there’s clear enterprise interest in building solutions with these services. A data leakage plan helps here too. “As

article thumbnail

10 Ways Machine Learning and AI Revolutionizes Medicine and Pharma

Altexsoft

According to McKinsey , machine learning and artificial intelligence in pharma and medicine are going to revolutionize the industries to help them make better decisions, optimize innovations, improve the efficiency of clinical and research trials, and provide for new tools for physicians, consumers, regulators, and even insurers.